Cancer (Oncology)
Cancer (Oncology)
Tagrisso 40® Osimertinib Tablets
Osimertinib 40mg
- Composition
- Osimertinib 40mg
- Dosage form
- Tablet
- Pack size
- Strip of 10 Tablet
- Manufacturer
- Astrazeneca
- Also known as
- Tagrisso
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Tagrisso 40 mg contains osimertinib, a targeted anticancer medicine used to treat certain forms of non-small cell lung cancer with specific EGFR mutations.
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Licensed wholesalerForm 20B & 21B, Delhi
Discreet packagingPlain outer box, no product labels
Worldwide shippingDirect to you or your customer